Breaking News Instant updates and real-time market news.

2020-02-06 04:55:00 OSTK Overstock.com $7.98 / +0.06 (+0.76%) , CRM Salesforce $185.50 / -2.82 (-1.50%) … 04:55 02/06/20 02/06 04:55 02/06/20 04:55	MicroStrategy to hold a user conference Microstrategy World 2020 will be held in Orlando on February 4-6. OSTK Overstock.com $7.98 / +0.06 (+0.76%) CRM Salesforce $185.50 / -2.82 (-1.50%) FMCC Freddie Mac $0.00 / + (+0.00%) TAK Takeda Pharmaceutical $19.98 / + (+0.00%) SAH Sonic Automotive $33.50 / +1.15 (+3.55%) GOOG Alphabet $1,448.65 / +1.36 (+0.09%) MCD McDonald's $214.42 / -0.24 (-0.11%) UNH UnitedHealth $295.77 / +14.92 (+5.31%) VSLR Vivint Solar $8.79 / +0.675 (+8.32%) VRTX Vertex Pharmaceuticals $240.67 / +0.94 (+0.39%) MELI MercadoLibre $675.34 / -34.36 (-4.84%) TRI Thomson Reuters $80.28 / -1.235 (-1.52%) ADS Alliance Data $106.85 / +4.44 (+4.34%) CASY Casey's General Stores $163.06 / +1.21 (+0.75%) SNY Sanofi $49.29 / +0.67 (+1.38%) TLND Talend $36.04 / -0.59 (-1.61%) IQV Iqvia $159.76 / +2.78 (+1.77%) V Visa $202.76 / -0.8 (-0.39%) UBS UBS $12.77 / +0.305 (+2.45%) CTSH Cognizant $65.01 / +1.58 (+2.49%) SCGLY Societe Generale $0.00 / + (+0.00%) DTEGY Deutsche Telekom $0.00 / + (+0.00%) MSTR MicroStrategy $152.97 / +0.58 (+0.38%)	06 Feb 10 Feb 10 Feb 11 Feb 11 Feb 12 Feb 12 Feb 13 Feb 13 Feb 13 Feb 13 Feb 13 Feb 19 Feb 25 Feb 25 Feb 27 Feb 06 Mar 09 Mar 13 Mar 17 Mar 19 Mar 19 Mar 26 May
OSTK CRM FMCC TAK SAH GOOG MCD UNH VSLR VRTX MELI TRI ADS CASY SNY TLND IQV V UBS CTSH SCGLY DTEGY MSTR OSTK Overstock.com $7.98 / +0.06 (+0.76%) 11/13/19 DA Davidson Overstock.com price target lowered to $25 from $48 at DA Davidson 09/26/19 BofA Aaron's initiated with a Buy at BofA/Merrill 09/19/19 DA Davidson Overstock.com stake sale by former CEO Byrne a positive, says DA Davidson 07/16/19 Maxim Overstock.com resumed with a Buy at Maxim CRM Salesforce $185.50 / -2.82 (-1.50%) 01/27/20 Cleveland Research Salesforce Q4 seems to be tracking ahead of expectation, says Cleveland Research 01/20/20 BMO Capital BMO keeps 'top pick' status on Salesforce, boosts price target to $210 01/16/20 Wells Fargo Salesforce price target raised to $215 from $185 at Wells Fargo 01/13/20 Credit Suisse Salesforce price target raised to $215 form $185 at Credit Suisse FMCC Freddie Mac $0.00 / + (+0.00%) 02/05/20 Pershing sees 'substantial' share appreciation for Fannie, Freddie 01/08/20 Odeon Capital GSE stocks likely to move on Supreme Court review decision, says Odeon Capital 01/07/20 Nomura Freddie Mac initiated with a Buy at Nomura Instinet 12/09/19 Odeon Capital Odeon says ruling seems like 'big, big plus' for Fannie and Freddie shareholders TAK Takeda Pharmaceutical $19.98 / + (+0.00%) 11/19/19 Needham Phathom Pharmaceuticals initiated with a Buy at Needham 11/01/19 Cowen Takeda Pharmaceutical initiated with a Market Perform at Cowen 09/24/19 Jefferies Takeda Pharmaceutical initiated with a Buy at Jefferies 09/05/19 H.C. Wainwright H.C. Wainwright says KemPharm may have picked 'best possible' partner in GPC SAH Sonic Automotive $33.50 / +1.15 (+3.55%) 01/07/20 JPMorgan JPMorgan sees attractive entry points following Auto Dealerships selloff 11/14/19 Morgan Stanley Sonic Automotive upgraded to Equal Weight from Underweight at Morgan Stanley 09/13/19 BofA Asbury Automotive, Adient, Aptiv cut to Neutral from Buy at BofA/Merrill 09/13/19 BofA Sonic Automotive downgraded to Underperform from Neutral at BofA/Merrill GOOG Alphabet $1,448.65 / +1.36 (+0.09%) 02/04/20 JPMorgan Alphabet price target raised to $1,535 from $1,460 at JPMorgan 02/04/20 Canaccord Alphabet results weakness should be short-lived, says Canaccord 02/04/20 Morgan Stanley Morgan Stanley says YouTube smaller, but faster growing, than expected 02/04/20 Oppenheimer Alphabet price target raised to $1,620 from $1,530 at Oppenheimer MCD McDonald's $214.42 / -0.24 (-0.11%) 01/30/20 MKM Partners McDonald's price target raised to $245 from $225 at MKM Partners 01/30/20 Baird McDonald's price target raised to $230 from $218 at Baird 01/30/20 BMO Capital McDonald's price target raised to $235 from $225 at BMO Capital 01/28/20 Longbow McDonald's took U.S. share from Burger King in late Q4, early Q1, says Longbow UNH UnitedHealth $295.77 / +14.92 (+5.31%) 01/21/20 Cantor Fitzgerald CVS, Cigna and Centene a buy on any block grant selloff, says Cantor 01/16/20 Truist UnitedHealth price target raised to $360 from $350 at SunTrust 01/16/20 Oppenheimer UnitedHealth price target raised to $343 from $312 at Oppenheimer 01/16/20 Cantor Fitzgerald UnitedHealth price target raised to $330 from $315 at Cantor Fitzgerald VSLR Vivint Solar $8.79 / +0.675 (+8.32%) 01/30/20 Credit Suisse Tesla signals strong residential solar growth, says Credit Suisse 09/30/19 Citi Vivint Solar selloff on short report overdone, says Citi 08/20/19 Fly Intel: Top five analyst initiations 08/20/19 KeyBanc bullish on Sunnova Energy, initiates with an Overweight VRTX Vertex Pharmaceuticals $240.67 / +0.94 (+0.39%) 01/31/20 Baird Baird cuts Vertex to Neutral on valuation after Trikafta 'smokes expectations' 01/31/20 RBC Capital Vertex price target raised to $260 from $240 at RBC Capital 01/31/20 Truist Vertex price target raised to $285 from $235 at SunTrust 01/31/20 JPMorgan Vertex price target raised to $260 from $247 at JPMorgan MELI MercadoLibre $675.34 / -34.36 (-4.84%) 02/05/20 Susquehanna MercadoLibre upgraded to Positive at Susquehanna 02/05/20 Susquehanna MercadoLibre upgraded to Positive from Neutral at Susquehanna 01/22/20 Piper Sandler MercadoLibre price target raised to $760 from $675 at Piper Sandler 01/21/20 Bradesco BBI MercadoLibre downgraded to Neutral from Outperform at Bradesco TRI Thomson Reuters $80.28 / -1.235 (-1.52%) 01/08/20 BofA Thomson Reuters named top Business and Information Services pick at BofA 11/11/19 BofA Thomson Reuters upgraded to Buy from Neutral at BofA/Merrill 08/21/19 TD Securities Thomson Reuters downgraded to Hold from Buy at TD Securities 07/29/19 Thomson Reuters upgraded to Outperform at Credit Suisse ADS Alliance Data $106.85 / +4.44 (+4.34%) 01/14/20 Argus Alliance Data downgraded to Hold from Buy at Argus 12/02/19 BofA Alliance Data resumed with a Neutral at BofA/Merrill 11/11/19 Fly Intel: Top five analyst upgrades 11/11/19 Oppenheimer Alliance Data upgraded to Outperform from Perform at Oppenheimer CASY Casey's General Stores $163.06 / +1.21 (+0.75%) 12/11/19 BMO Capital Casey's General Stores price target lowered to $165 from $170 at BMO Capital 09/11/19 Stephens Casey's General Stores price target raised to $197 from $181 at Stephens 09/11/19 BMO Capital Casey's General Stores price target raised to $170 from $140 at BMO Capital 09/11/19 Wells Fargo Casey's General Stores price target raised to $165 form $145 at Wells Fargo SNY Sanofi $49.29 / +0.67 (+1.38%) 01/26/20 Goldman Sachs Denali Therapeutics upgraded to Buy from Neutral at Goldman Sachs 01/22/20 Liberum Sanofi downgraded to Hold from Buy at Liberum (earlier) 01/22/20 Oppenheimer Regeneron price target raised to $450 from $430 at Oppenheimer 01/13/20 Piper Sandler Regeneron's U.S. Eylea sales beat consensus, says Piper Sandler TLND Talend $36.04 / -0.59 (-1.61%) 06/12/19 Citi Citi sees competitive bidding process for Tableau as unlikely 06/07/19 Goldman Sachs Talend initiated with a Sell at Goldman Sachs 04/08/19 KeyBanc Talend price target raised to $65 from $52 at KeyBanc 03/25/19 BTIG Talend price target raised to $62 from $50 at BTIG IQV Iqvia $159.76 / +2.78 (+1.77%) 01/13/20 Morgan Stanley Veeva upgraded to Overweight following underperformance at Morgan Stanley 01/07/20 Wells Fargo Wells Fargo initiates Life Science Tools, Services, Diagnostics Sector 01/07/20 Wells Fargo Iqvia initiated with an Overweight at Wells Fargo 01/06/20 Citi Iqvia initiated with a Buy at Citi V Visa $202.76 / -0.8 (-0.39%) 02/03/20 BMO Capital Visa price target lowered to $229 from $232 at BMO Capital 02/03/20 KeyBanc Visa price target raised to $215 from $210 at KeyBanc 01/31/20 Truist Visa price target raised to $230 from $205 at SunTrust 01/31/20 Cantor Fitzgerald Visa price target raised to $228 from $200 at Cantor Fitzgerald UBS UBS $12.77 / +0.305 (+2.45%) 10/22/19 Evercore ISI Waddell & Reed downgraded at Evercore ISI after UBS announces new initiative 10/22/19 Evercore ISI UBS initiative to pressure retail asset managers like Invesco, says Evercore ISI 09/10/19 Kepler Cheuvreux UBS upgraded to Buy from Hold at Kepler Cheuvreux 08/30/19 Fly Intel: Top analyst downgrade CTSH Cognizant $65.01 / +1.58 (+2.49%) 01/21/20 Berenberg Cognizant initiated with a Hold at Berenberg 01/09/20 Wells Fargo ASGN price target raised to $80 from $75 at Wells Fargo 01/09/20 Wells Fargo Wells Fargo changes three ratings in Commercial IT Services heading into 2020 01/09/20 Wells Fargo Cognizant upgraded to Overweight from Equal Weight at Wells Fargo SCGLY Societe Generale $0.00 / + (+0.00%) 11/29/19 Barclays Societe Generale upgraded to Overweight from Equal Weight at Barclays 11/11/19 Keefe Bruyette Societe Generale upgraded to Market Perform from Underperform at Keefe Bruyette 10/01/19 UBS Societe Generale downgraded to Neutral from Buy at UBS 08/02/19 Citi Societe Generale upgraded to Buy from Neutral at Citi DTEGY Deutsche Telekom $0.00 / + (+0.00%) 01/24/20 Jefferies to hold a field trip to Germany 11/11/19 Barclays Deutsche Telekom downgraded to Underweight from Equal Weight at Barclays 10/24/19 Citi Deutsche Telekom downgraded to Neutral from Buy at Citi 07/17/19 Macquarie Deutsche Telekom downgraded to Underperform from Neutral at Macquarie MSTR MicroStrategy $152.97 / +0.58 (+0.38%) 10/30/19 Citi MicroStrategy's execution challenges resurface, says Citi 06/12/19 First Analysis Tableau downgraded to Neutral from Outperform at First Analysis 04/22/19 BWS Financial MicroStrategy buybacks warrant investor attention, says BWS Financial 02/11/19 Fly Intel: Top five analyst initiations

2020-02-06 04:55:00

OSTK

Overstock.com

$7.98 / +0.06 (+0.76%)

, CRM

Salesforce

$185.50 / -2.82 (-1.50%)

… 04:55

02/06/20

02/06

04:55

02/06/20

04:55

MicroStrategy to hold a user conference

Microstrategy World 2020 will be held in Orlando on February 4-6.

OSTK

Overstock.com

$7.98 / +0.06 (+0.76%)

CRM

Salesforce

$185.50 / -2.82 (-1.50%)

FMCC

Freddie Mac

$0.00 / + (+0.00%)

TAK

Takeda Pharmaceutical

$19.98 / + (+0.00%)

SAH

Sonic Automotive

$33.50 / +1.15 (+3.55%)

GOOG

Alphabet

$1,448.65 / +1.36 (+0.09%)

MCD

McDonald's

$214.42 / -0.24 (-0.11%)

UNH

UnitedHealth

$295.77 / +14.92 (+5.31%)

VSLR

Vivint Solar

$8.79 / +0.675 (+8.32%)

VRTX

Vertex Pharmaceuticals

$240.67 / +0.94 (+0.39%)

MELI

MercadoLibre

$675.34 / -34.36 (-4.84%)

TRI

Thomson Reuters

$80.28 / -1.235 (-1.52%)

ADS

Alliance Data

$106.85 / +4.44 (+4.34%)

CASY

Casey's General Stores

$163.06 / +1.21 (+0.75%)

SNY

Sanofi

$49.29 / +0.67 (+1.38%)

TLND

Talend

$36.04 / -0.59 (-1.61%)

IQV

Iqvia

$159.76 / +2.78 (+1.77%)

Visa

$202.76 / -0.8 (-0.39%)

UBS

$12.77 / +0.305 (+2.45%)

CTSH

Cognizant

$65.01 / +1.58 (+2.49%)

SCGLY

Societe Generale

$0.00 / + (+0.00%)

DTEGY

Deutsche Telekom

$0.00 / + (+0.00%)

MSTR

MicroStrategy

$152.97 / +0.58 (+0.38%)

06
Feb
10
Feb
10
Feb
11
Feb
11
Feb
12
Feb
12
Feb
13
Feb
13
Feb
13
Feb
13
Feb
13
Feb
19
Feb
25
Feb
25
Feb
27
Feb
06
Mar
09
Mar
13
Mar
17
Mar
19
Mar
19
Mar
26
May

OSTK
CRM
FMCC
TAK
SAH
GOOG
MCD
UNH
VSLR
VRTX
MELI
TRI
ADS
CASY
SNY
TLND
IQV
V
UBS
CTSH
SCGLY
DTEGY
MSTR

OSTK Overstock.com

$7.98 / +0.06 (+0.76%)

11/13/19 DA Davidson: Overstock.com price target lowered to $25 from $48 at DA Davidson

09/26/19 BofA: Aaron's initiated with a Buy at BofA/Merrill

09/19/19 DA Davidson: Overstock.com stake sale by former CEO Byrne a positive, says DA Davidson

07/16/19 Maxim: Overstock.com resumed with a Buy at Maxim

CRM Salesforce

$185.50 / -2.82 (-1.50%)

01/27/20 Cleveland Research: Salesforce Q4 seems to be tracking ahead of expectation, says Cleveland Research

01/20/20 BMO Capital: BMO keeps 'top pick' status on Salesforce, boosts price target to $210

01/16/20 Wells Fargo: Salesforce price target raised to $215 from $185 at Wells Fargo

01/13/20 Credit Suisse: Salesforce price target raised to $215 form $185 at Credit Suisse

FMCC Freddie Mac

$0.00 / + (+0.00%)

02/05/20: Pershing sees 'substantial' share appreciation for Fannie, Freddie

01/08/20 Odeon Capital: GSE stocks likely to move on Supreme Court review decision, says Odeon Capital

01/07/20 Nomura: Freddie Mac initiated with a Buy at Nomura Instinet

12/09/19 Odeon Capital: Odeon says ruling seems like 'big, big plus' for Fannie and Freddie shareholders

TAK Takeda Pharmaceutical

$19.98 / + (+0.00%)

11/19/19 Needham: Phathom Pharmaceuticals initiated with a Buy at Needham

11/01/19 Cowen: Takeda Pharmaceutical initiated with a Market Perform at Cowen

09/24/19 Jefferies: Takeda Pharmaceutical initiated with a Buy at Jefferies

09/05/19 H.C. Wainwright: H.C. Wainwright says KemPharm may have picked 'best possible' partner in GPC

SAH Sonic Automotive

$33.50 / +1.15 (+3.55%)

01/07/20 JPMorgan: JPMorgan sees attractive entry points following Auto Dealerships selloff

11/14/19 Morgan Stanley: Sonic Automotive upgraded to Equal Weight from Underweight at Morgan Stanley

09/13/19 BofA: Asbury Automotive, Adient, Aptiv cut to Neutral from Buy at BofA/Merrill

09/13/19 BofA: Sonic Automotive downgraded to Underperform from Neutral at BofA/Merrill

GOOG Alphabet

$1,448.65 / +1.36 (+0.09%)

02/04/20 JPMorgan: Alphabet price target raised to $1,535 from $1,460 at JPMorgan

02/04/20 Canaccord: Alphabet results weakness should be short-lived, says Canaccord

02/04/20 Morgan Stanley: Morgan Stanley says YouTube smaller, but faster growing, than expected

02/04/20 Oppenheimer: Alphabet price target raised to $1,620 from $1,530 at Oppenheimer

MCD McDonald's

$214.42 / -0.24 (-0.11%)

01/30/20 MKM Partners: McDonald's price target raised to $245 from $225 at MKM Partners

01/30/20 Baird: McDonald's price target raised to $230 from $218 at Baird

01/30/20 BMO Capital: McDonald's price target raised to $235 from $225 at BMO Capital

01/28/20 Longbow: McDonald's took U.S. share from Burger King in late Q4, early Q1, says Longbow

UNH UnitedHealth

$295.77 / +14.92 (+5.31%)

01/21/20 Cantor Fitzgerald: CVS, Cigna and Centene a buy on any block grant selloff, says Cantor

01/16/20 Truist: UnitedHealth price target raised to $360 from $350 at SunTrust

01/16/20 Oppenheimer: UnitedHealth price target raised to $343 from $312 at Oppenheimer

01/16/20 Cantor Fitzgerald: UnitedHealth price target raised to $330 from $315 at Cantor Fitzgerald

VSLR Vivint Solar

$8.79 / +0.675 (+8.32%)

01/30/20 Credit Suisse: Tesla signals strong residential solar growth, says Credit Suisse

09/30/19 Citi: Vivint Solar selloff on short report overdone, says Citi

08/20/19: Fly Intel: Top five analyst initiations

08/20/19: KeyBanc bullish on Sunnova Energy, initiates with an Overweight

VRTX Vertex Pharmaceuticals

$240.67 / +0.94 (+0.39%)

01/31/20 Baird: Baird cuts Vertex to Neutral on valuation after Trikafta 'smokes expectations'

01/31/20 RBC Capital: Vertex price target raised to $260 from $240 at RBC Capital

01/31/20 Truist: Vertex price target raised to $285 from $235 at SunTrust

01/31/20 JPMorgan: Vertex price target raised to $260 from $247 at JPMorgan

MELI MercadoLibre

$675.34 / -34.36 (-4.84%)

02/05/20 Susquehanna: MercadoLibre upgraded to Positive at Susquehanna

02/05/20 Susquehanna: MercadoLibre upgraded to Positive from Neutral at Susquehanna

01/22/20 Piper Sandler: MercadoLibre price target raised to $760 from $675 at Piper Sandler

01/21/20 Bradesco BBI: MercadoLibre downgraded to Neutral from Outperform at Bradesco

TRI Thomson Reuters

$80.28 / -1.235 (-1.52%)

01/08/20 BofA: Thomson Reuters named top Business and Information Services pick at BofA

11/11/19 BofA: Thomson Reuters upgraded to Buy from Neutral at BofA/Merrill

08/21/19 TD Securities: Thomson Reuters downgraded to Hold from Buy at TD Securities

07/29/19: Thomson Reuters upgraded to Outperform at Credit Suisse

ADS Alliance Data

$106.85 / +4.44 (+4.34%)

01/14/20 Argus: Alliance Data downgraded to Hold from Buy at Argus

12/02/19 BofA: Alliance Data resumed with a Neutral at BofA/Merrill

11/11/19: Fly Intel: Top five analyst upgrades

11/11/19 Oppenheimer: Alliance Data upgraded to Outperform from Perform at Oppenheimer

CASY Casey's General Stores

$163.06 / +1.21 (+0.75%)

12/11/19 BMO Capital: Casey's General Stores price target lowered to $165 from $170 at BMO Capital

09/11/19 Stephens: Casey's General Stores price target raised to $197 from $181 at Stephens

09/11/19 BMO Capital: Casey's General Stores price target raised to $170 from $140 at BMO Capital

09/11/19 Wells Fargo: Casey's General Stores price target raised to $165 form $145 at Wells Fargo

SNY Sanofi

$49.29 / +0.67 (+1.38%)

01/26/20 Goldman Sachs: Denali Therapeutics upgraded to Buy from Neutral at Goldman Sachs

01/22/20 Liberum: Sanofi downgraded to Hold from Buy at Liberum (earlier)

01/22/20 Oppenheimer: Regeneron price target raised to $450 from $430 at Oppenheimer

01/13/20 Piper Sandler: Regeneron's U.S. Eylea sales beat consensus, says Piper Sandler

TLND Talend

$36.04 / -0.59 (-1.61%)

06/12/19 Citi: Citi sees competitive bidding process for Tableau as unlikely

06/07/19 Goldman Sachs: Talend initiated with a Sell at Goldman Sachs

04/08/19 KeyBanc: Talend price target raised to $65 from $52 at KeyBanc

03/25/19 BTIG: Talend price target raised to $62 from $50 at BTIG

IQV Iqvia

$159.76 / +2.78 (+1.77%)

01/13/20 Morgan Stanley: Veeva upgraded to Overweight following underperformance at Morgan Stanley

01/07/20 Wells Fargo: Wells Fargo initiates Life Science Tools, Services, Diagnostics Sector

01/07/20 Wells Fargo: Iqvia initiated with an Overweight at Wells Fargo

01/06/20 Citi: Iqvia initiated with a Buy at Citi

V Visa

$202.76 / -0.8 (-0.39%)

02/03/20 BMO Capital: Visa price target lowered to $229 from $232 at BMO Capital

02/03/20 KeyBanc: Visa price target raised to $215 from $210 at KeyBanc

01/31/20 Truist: Visa price target raised to $230 from $205 at SunTrust

01/31/20 Cantor Fitzgerald: Visa price target raised to $228 from $200 at Cantor Fitzgerald

UBS UBS

$12.77 / +0.305 (+2.45%)

10/22/19 Evercore ISI: Waddell & Reed downgraded at Evercore ISI after UBS announces new initiative

10/22/19 Evercore ISI: UBS initiative to pressure retail asset managers like Invesco, says Evercore ISI

09/10/19 Kepler Cheuvreux: UBS upgraded to Buy from Hold at Kepler Cheuvreux

08/30/19: Fly Intel: Top analyst downgrade

CTSH Cognizant

$65.01 / +1.58 (+2.49%)

01/21/20 Berenberg: Cognizant initiated with a Hold at Berenberg

01/09/20 Wells Fargo: ASGN price target raised to $80 from $75 at Wells Fargo

01/09/20 Wells Fargo: Wells Fargo changes three ratings in Commercial IT Services heading into 2020

01/09/20 Wells Fargo: Cognizant upgraded to Overweight from Equal Weight at Wells Fargo

SCGLY Societe Generale

$0.00 / + (+0.00%)

11/29/19 Barclays: Societe Generale upgraded to Overweight from Equal Weight at Barclays

11/11/19 Keefe Bruyette: Societe Generale upgraded to Market Perform from Underperform at Keefe Bruyette

10/01/19 UBS: Societe Generale downgraded to Neutral from Buy at UBS

08/02/19 Citi: Societe Generale upgraded to Buy from Neutral at Citi

DTEGY Deutsche Telekom

$0.00 / + (+0.00%)

01/24/20: Jefferies to hold a field trip to Germany

11/11/19 Barclays: Deutsche Telekom downgraded to Underweight from Equal Weight at Barclays

10/24/19 Citi: Deutsche Telekom downgraded to Neutral from Buy at Citi

07/17/19 Macquarie: Deutsche Telekom downgraded to Underperform from Neutral at Macquarie

MSTR MicroStrategy

$152.97 / +0.58 (+0.38%)

10/30/19 Citi: MicroStrategy's execution challenges resurface, says Citi

06/12/19 First Analysis: Tableau downgraded to Neutral from Outperform at First Analysis

04/22/19 BWS Financial: MicroStrategy buybacks warrant investor attention, says BWS Financial

02/11/19: Fly Intel: Top five analyst initiations

TODAY'S FREE FLY STORIES

Downgrade	Kone OYJ downgraded to Neutral from Buy at Oddo BHF » 05:27 01/22/21 01/22 05:27 01/22/21 05:27 KNYJY Kone OYJ $0.00 / + (+0.00%) Oddo BHF analyst Delphine… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research KNYJY Kone OYJ $0.00 / + (+0.00%) 01/13/21 Barclays Kone OYJ price target lowered to EUR 58 from EUR 60 at Barclays 12/10/20 Kepler Cheuvreux Kone OYJ upgraded to Buy from Hold at Kepler Cheuvreux 12/07/20 JPMorgan Kone OYJ price target raised to EUR 75 from EUR 74 at JPMorgan 12/01/20 Exane BNP Paribas Kone OYJ downgraded to Neutral from Outperform at Exane BNP Paribas
Downgrade	Schindler downgraded to Reduce from Neutral at Oddo BHF » 05:27 01/22/21 01/22 05:27 01/22/21 05:27 SHLAF Schindler $0.00 / + (+0.00%) Oddo BHF analyst Delphine… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research SHLAF Schindler $0.00 / + (+0.00%) 01/13/21 Barclays Schindler price target lowered to CHF 210 from CHF 220 at Barclays 12/10/20 Kepler Cheuvreux Schindler downgraded to Hold from Buy at Kepler Cheuvreux 12/08/20 Commerzbank Schindler initiated with a Reduce at Commerzbank 12/01/20 Exane BNP Paribas Schindler downgraded to Underperform from Neutral at Exane BNP Paribas
Downgrade	DBV Technologies downgraded to Sell from Hold at Societe Generale » 05:25 01/22/21 01/22 05:25 01/22/21 05:25 DBVT DBV Technologies $6.51 / +0.02 (+0.31%) Societe Generale analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly DBVT DBV Technologies $6.51 / +0.02 (+0.31%) 01/15/21 DBV Technologies gets feedback from FDA regarding Viaskin Peanut regulatory path 01/07/21 DBV Technologies restructuring plan to result in reduction of over 200 jobs 11/24/20 DBV Technologies CSO Hugh Sampson to step down from role 11/02/20 DBV Technologies receives validation for Viaskin Peanut MAA by EMA DBVT DBV Technologies $6.51 / +0.02 (+0.31%) 01/18/21 Goldman Sachs DBV Technologies price target raised to $7 from $4 at Goldman Sachs 01/15/21 Citi DBV Technologies price target raised to $8 from $4 at Citi 01/15/21 H.C. Wainwright DBV now has 'clear developmental path,' says H.C. Wainwright 11/02/20 Societe Generale DBV Technologies upgraded to Hold on improved visibility at Societe Generale DBVT DBV Technologies $6.51 / +0.02 (+0.31%) 07/31/20 DBV Technologies reports first half EPS EUR (1.62) vs. EUR (2.43) last year 30 Jan DBVT DBV Technologies $6.51 / +0.02 (+0.31%) 01/15/21 Fly Intel: Wall Street's top stories for Friday 01/15/21 Fly Intel: Wall Street's top stories at midday 01/15/21 Fly Intel: Pre-market Movers 11/02/20 Fly Intel: Pre-market Movers
Initiation	Sage Group initiated with a Buy at Peel Hunt » 05:24 01/22/21 01/22 05:24 01/22/21 05:24 SGPYY Sage Group $0.00 / + (+0.00%) Peel Hunt analyst Damindu… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research SGPYY Sage Group $0.00 / + (+0.00%) 01/14/21 Sage Group says AgeMark moves to Sage Intacct solution 12/16/20 Sage announces Sage Partner Cloud Program in the U.S., Canada SGPYY Sage Group $0.00 / + (+0.00%) 01/11/21 Canaccord Sage Group price target lowered to 680 GBp from 700 GBp at Canaccord 12/10/20 Morgan Stanley Sage Group upgraded to Equal Weight from Underweight at Morgan Stanley 11/25/20 JPMorgan Sage Group price target lowered to 560 GBp from 600 GBp at JPMorgan 11/24/20 UBS Sage Group price target lowered to 550 GBp from 610 GBp at UBS
Downgrade	Gerresheimer downgraded to Hold from Buy at Pareto » 05:22 01/22/21 01/22 05:22 01/22/21 05:22 GRRMF Gerresheimer $0.00 / + (+0.00%) Pareto analyst Zafer… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research GRRMF Gerresheimer $0.00 / + (+0.00%) 07/29/20 Berenberg Gerresheimer price target raised to EUR 115 from EUR 75 at Berenberg

Downgrade	Siltronic downgraded to Neutral from Buy at Oddo BHF » 05:21 01/22/21 01/22 05:21 01/22/21 05:21 SSLLF Siltronic $0.00 / + (+0.00%) Oddo BHF analyst Stephane… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research SSLLF Siltronic $0.00 / + (+0.00%) 01/12/21 Deutsche Bank Siltronic price target raised to EUR 150 from EUR 135 at Deutsche Bank 12/11/20 Jefferies Siltronic downgraded to Hold from Buy at Jefferies 12/04/20 UBS Siltronic price target raised to EUR 125 from EUR 85 at UBS 12/02/20 Berenberg Siltronic price target raised to EUR 125 from EUR 85 at Berenberg
Upgrade	Carl Zeiss Meditec upgraded to Hold from Sell at DZ Bank » 05:20 01/22/21 01/22 05:20 01/22/21 05:20 CZMWY Carl Zeiss Meditec $0.00 / + (+0.00%) DZ Bank analyst Sven… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research CZMWY Carl Zeiss Meditec $0.00 / + (+0.00%) 10/07/20 Microsoft, Zeiss announce multi-year strategic partnership CZMWY Carl Zeiss Meditec $0.00 / + (+0.00%) 01/20/21 Berenberg Carl Zeiss Meditec price target raised to EUR 127 from EUR 87 at Berenberg 01/20/21 Deutsche Bank Carl Zeiss Meditec price target raised to EUR 140 from EUR 120 at Deutsche Bank 11/02/20 Deutsche Bank Carl Zeiss Meditec price target raised to EUR 120 from EUR 110 at Deutsche Bank 10/23/20 UBS Carl Zeiss Meditec downgraded to Neutral from Buy at UBS
Upgrade	Ericsson upgraded to Buy from Hold at Nordea » 05:19 01/22/21 01/22 05:19 01/22/21 05:19 ERIC Ericsson $11.77 / -0.08 (-0.68%) Nordea analyst Sami… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals Events Options ERIC Ericsson $11.77 / -0.08 (-0.68%) 01/13/21 T-Mobile announces five-year agreements with Ericsson, Nokia 12/17/20 Nokia appoints Nishant Batra as chief strategy, technology officer 12/17/20 Veoneer CTO Nishant Batra to leave for Nokia, Giuseppe Rosso named acting CTO 11/10/20 Ericsson announces new long-term financial targets at Capital Markets Day ERIC Ericsson $11.77 / -0.08 (-0.68%) 01/14/21 Barclays Ericsson price target lowered to SEK 120 from SEK 125 at Barclays 11/20/20 UBS Ericsson price target raised to SEK 102 from SEK 86 at UBS 11/12/20 Societe Generale Ericsson upgraded to Buy from Hold at Societe Generale 10/22/20 Barclays Ericsson price target raised to SEK 125 from SEK 110 at Barclays ERIC Ericsson $11.77 / -0.08 (-0.68%) 10/21/20 Ericsson reports Q3 EPS SEK 1.61 vs. (SEK 1.89) last year ERIC Ericsson $11.77 / -0.08 (-0.68%) 01/08/21 Samsung files ITC case to block Ericsson 5G imports, Bloomberg reports 10/20/20 Swedish regulators ban Huawei, ZTE from upcoming 5G networks, Reuters reports 02/11/21 Technology & Internet Virtual Conference 01/29/21 Ericsson - ERIC ERIC Ericsson $11.77 / -0.08 (-0.68%) 01/05/21 Unusually active option classes on open January 5th 11/10/20 Ericsson put volume heavy and directionally bearish 10/14/20 Ericsson call volume above normal and directionally bullish 10/13/20 Unusually active option classes on open October 13th
Downgrade	Syrah Resources downgraded to Neutral from Outperform at Credit Suisse » 05:18 01/22/21 01/22 05:18 01/22/21 05:18 SYAAF Syrah Resources $0.00 / + (+0.00%) Credit Suisse analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial
Downgrade	Air France-KLM downgraded to Reduce from Hold at Kepler Cheuvreux » 05:18 01/22/21 01/22 05:18 01/22/21 05:18 AFLYY Air France-KLM $0.00 / + (+0.00%) Kepler Cheuvreux analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals AFLYY Air France-KLM $0.00 / + (+0.00%) 12/04/20 KLM, Delta to offer COVID-19 tested flights from Atlanta to Amsterdam AFLYY Air France-KLM $0.00 / + (+0.00%) 01/20/21 Barclays Air France-KLM price target raised to EUR 5.10 from EUR 2.70 at Barclays 12/04/20 Deutsche Bank Air France-KLM price target raised to EUR 3.50 from EUR 2.10 at Deutsche Bank 12/01/20 UBS Air France-KLM price target raised to EUR 4.45 from EUR 3.35 at UBS 11/12/20 Kepler Cheuvreux Air France-KLM upgraded to Hold from Reduce at Kepler Cheuvreux AFLYY Air France-KLM $0.00 / + (+0.00%) 07/30/20 Air France-KLM sees 'significantly negative' EBITDA in second half 07/30/20 Air France-KLM reports Q2 revenue EUR 1.18B vs. EUR 7.02B last year AFLYY Air France-KLM $0.00 / + (+0.00%) 12/22/20 Germany extends U.K. travel ban to January 6, Sky News reports 09/24/20 KLM steps up labor talks aimed to securing wage cuts, Bloomberg reports 09/01/20 Air France-KLM plans to raise funds by May of next year, Bloomberg reports

Downgrade	Alstom downgraded to Hold from Buy at Kepler Cheuvreux » 05:17 01/22/21 01/22 05:17 01/22/21 05:17 ALSMY Alstom $0.00 / + (+0.00%) Kepler Cheuvreux analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Periodicals ALSMY Alstom $0.00 / + (+0.00%) 12/01/20 Bombardier, Alstom confirm receipt of all necessary approvals for transaction 09/16/20 Bombardier announces SPA for sale of transportation business to Alstom 07/31/20 European Commission clears Alstom's acquisition of Bombardier Transportation 07/28/20 Linde to begin construction on hydrogen refueling station for trains in Germany ALSMY Alstom $0.00 / + (+0.00%) 01/20/21 Jefferies Alstom upgraded to Buy from Hold at Jefferies 01/12/21 Deutsche Bank Alstom price target raised to EUR 47 from EUR 45 at Deutsche Bank 12/11/20 Credit Suisse Alstom upgraded to Outperform from Neutral at Credit Suisse 12/08/20 Morgan Stanley Alstom price target raised to EUR 55 from EUR 51 at Morgan Stanley ALSMY Alstom $0.00 / + (+0.00%) 07/27/20 EU set to approve with conditions Alstom, Bombardier deal, Reuters reports
Downgrade	IAG downgraded to Reduce from Hold at Kepler Cheuvreux » 05:17 01/22/21 01/22 05:17 01/22/21 05:17 ICAGY IAG $0.00 / + (+0.00%) Kepler Cheuvreux analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Periodicals ICAGY IAG $0.00 / + (+0.00%) 07/24/20 IAG 'evaluating the merits of a rights issue' of up to EUR 2.75B ICAGY IAG $0.00 / + (+0.00%) 01/20/21 Barclays IAG price target raised to 175 GBp from 120 GBp at Barclays 12/31/20 Fly Intel: Top five analyst calls 12/31/20 Citi IAG upgraded to Buy from Neutral at Citi 12/04/20 Deutsche Bank IAG price target raised to 220 GBp from 175 GBp at Deutsche Bank ICAGY IAG $0.00 / + (+0.00%) 12/07/20 IAG dismisses Ryanair comments on British Airways holding, Reuters says 11/05/20 British Airways to reduce flight schedule in November, Reuters reports
Upgrade	Adient upgraded to Neutral from Underweight at JPMorgan » 05:16 01/22/21 01/22 05:16 01/22/21 05:16 ADNT Adient $35.26 / -0.71 (-1.97%) JPMorgan analyst Ryan… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events ADNT Adient $35.26 / -0.71 (-1.97%) 08/14/20 Greenlight Capital exits Altice, takes stake in Atlas Air ADNT Adient $35.26 / -0.71 (-1.97%) 01/20/21 Deutsche Bank Adient price target raised to $43 from $37 at Deutsche Bank 12/17/20 Barclays Adient price target raised to $45 from $37 at Barclays 12/16/20 KeyBanc Adient price target raised to $43 from $36 at KeyBanc 12/02/20 Deutsche Bank Adient price target raised to $37 from $27 at Deutsche Bank ADNT Adient $35.26 / -0.71 (-1.97%) 11/30/20 Adient sees FY21 revenue $14.6B-$15B, consensus $14.47B 11/30/20 Adient reports Q4 adj. EPS $1.15, consensus 71c 08/06/20 Adient sees Q4 revenue $3.3B-$3.5B, consensus $3.31B 08/06/20 Adient reports Q3 adj. EPS ($2.78), consensus ($2.08) 02/05/21 Adient - ADNT
Downgrade	Gentherm downgraded to Underweight from Neutral at JPMorgan » 05:16 01/22/21 01/22 05:16 01/22/21 05:16 THRM Gentherm $70.38 / -0.6 (-0.85%) JPMorgan analyst Ryan… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings THRM Gentherm $70.38 / -0.6 (-0.85%) 01/11/21 Gentherm appoints Betsy Meter to board of directors 01/04/21 Gentherm appoints Steve Fletcher as SVP, GM of Medical 10/29/20 Gentherm to delay Q3 conference call 10/15/20 Gentherm launches ASTOPAD Patient Warming System THRM Gentherm $70.38 / -0.6 (-0.85%) 12/23/20 Barrington Gentherm double downgraded to Underperform at Barrington following rally 12/23/20 Barrington Gentherm downgraded to Underperform from Outperform at Barrington 10/30/20 Roth Capital Gentherm price target raised to $53 from $44 at Roth Capital 10/22/20 JPMorgan Gentherm price target raised to $48 from $43 at JPMorgan THRM Gentherm $70.38 / -0.6 (-0.85%) 10/29/20 Gentherm sees Q4 product revenues $240M-$260M, consensus $228.41M 10/29/20 Gentherm reports Q3 adjusted EPS 91c, consensus 49c 08/04/20 Gentherm not providing update to FY20 guidance 08/04/20 Gentherm sees Q3 product revenues $210M-$240M, consensus $212.53M
Upgrade	Lear upgraded to Overweight from Neutral at JPMorgan » 05:16 01/22/21 01/22 05:16 01/22/21 05:16 LEA Lear $168.15 / +0.79 (+0.47%) JPMorgan analyst Ryan… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events LEA Lear $168.15 / +0.79 (+0.47%) 01/14/21 Cerence, Xevo collaborate for to deliver Cerence Pay payment capabilities 01/11/21 Lear partners with GrubHub to deliver ordering capabilities in FCA vehicles 11/18/20 Lear reinstates quarterly cash dividend at 25c per share 11/16/20 Paulson & Co. buys Lear, cuts Tiffany in Q3 LEA Lear $168.15 / +0.79 (+0.47%) 01/20/21 Deutsche Bank Lear price target raised to $165 from $150 at Deutsche Bank 01/08/21 Guggenheim Lear downgraded to Neutral from Buy at Guggenheim 12/17/20 Barclays Lear upgraded to Overweight from Equal Weight at Barclays 12/16/20 Argus Lear upgraded to Buy at Argus on high expected demand following COVID LEA Lear $168.15 / +0.79 (+0.47%) 10/30/20 Lear reinstates FY20 revenue view $16.35B-$16.65B, consensus $16.45B 10/30/20 Lear reports Q3 adj. EPS $3.73, consensus $3.14 08/04/20 Lear not providing FY20 guidance due to COVID-19 08/04/20 Lear reports Q2 adj. EPS ($4.14), consensus ($4.67) LEA Lear $168.15 / +0.79 (+0.47%) 12/19/20 Charged: Deutsche sees multiple EV winners, says buy Xpev 02/04/21 Lear - LEA

Downgrade	Visteon downgraded to Underweight from Neutral at JPMorgan » 05:16 01/22/21 01/22 05:16 01/22/21 05:16 VC Visteon $142.17 / +0.6 (+0.42%) JPMorgan analyst Ryan… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings VC Visteon $142.17 / +0.6 (+0.42%) 12/07/20 Cognex names Visteon CEO Lawande to board of directors VC Visteon $142.17 / +0.6 (+0.42%) 01/20/21 Deutsche Bank Visteon price target raised to $166 from $105 at Deutsche Bank 12/17/20 Barclays Visteon price target raised to $150 from $101 at Barclays 11/19/20 Baird Visteon price target raised to $130 from $105 at Baird 11/03/20 Goldman Sachs Visteon upgraded to Neutral from Sell at Goldman Sachs VC Visteon $142.17 / +0.6 (+0.42%) 10/29/20 Visteon reports Q3 adjusted EPS $1.36, consensus 50c 07/30/20 Visteon reports Q2 EPS ($1.62), consensus ($2.12)
Downgrade	Aptiv downgraded to Neutral from Overweight at JPMorgan » 05:15 01/22/21 01/22 05:15 01/22/21 05:15 APTV Aptiv $143.95 / -1.16 (-0.80%) JPMorgan analyst Ryan… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research Earnings Syndicate On The Fly Events APTV Aptiv $143.95 / -1.16 (-0.80%) 01/20/21 Deutsche Bank Aptiv price target raised to $160 from $120 at Deutsche Bank 12/22/20 Citi Citi 'very skeptical' of Apple car, says Tesla most direct competitor 12/17/20 Barclays Aptiv price target raised to $145 from $112 at Barclays 12/16/20 Argus Aptiv initiated with a Buy at Argus on 'attractive valuation' APTV Aptiv $143.95 / -1.16 (-0.80%) 10/29/20 Aptiv sees FY20 adj. EPS $1.65-$1.80, consensus $1.28 10/29/20 Aptiv reports Q3 ex-items EPS $1.13, consensus 76c 07/30/20 Aptiv not reporting Q3, FY20 guidance at this time 07/30/20 Aptiv reports Q2 EPS ex-items ($1.10), consensus ($1.38) 10 Jun APTV Aptiv $143.95 / -1.16 (-0.80%) 12/26/20 Charged: Apple's potential EV entry seen as 'Tesla bear case' 12/22/20 Apple rises as Wall Street digests report of self-driving car plans 09/18/20 Fly Intel: Wall Street's top stories at midday 02/11/21 Technology & Internet Virtual Conference 02/03/21 Aptiv - APTV
Downgrade	TGS-NOPEC downgraded to Sell from Neutral at UBS » 05:15 01/22/21 01/22 05:15 01/22/21 05:15 TGSGY TGS-NOPEC $0.00 / + (+0.00%) UBS analyst Amy Wong… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research TGSGY TGS-NOPEC $0.00 / + (+0.00%) 10/09/20 UBS TGS-NOPEC price target lowered to NOK 135 from NOK 145 at UBS 10/09/20 DNB Markets TGS-NOPEC downgraded to Sell from Hold at DNB Markets 10/09/20 Danske Bank TGS-NOPEC downgraded to Hold from Buy at Danske Bank 08/19/20 Fearnley TGS-NOPEC downgraded to Sell from Buy at Fearnley
Downgrade	Bunzl downgraded to Equal Weight from Overweight at Barclays » 05:14 01/22/21 01/22 05:14 01/22/21 05:14 BZLFF Bunzl $0.00 / + (+0.00%) Barclays analyst James… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial
Downgrade	Vifor Pharma downgraded to Sell from Neutral at UBS » 05:13 01/22/21 01/22 05:13 01/22/21 05:13 GNHAF Vifor Pharma / + UBS analyst Laura… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research GNHAF Vifor Pharma / + 11/09/20 Vifor Pharma, Angion sign licensing agreement for ANG-3777 commercialization 10/20/20 Vifor Pharma, Cara Therapeutics enter license agreement for Korsuva Injection GNHAF Vifor Pharma / + 05:13 Today UBS Vifor Pharma downgraded to Sell from Neutral at UBS 01/04/21 JPMorgan Vifor Pharma downgraded to Underweight from Neutral at JPMorgan 10/22/20 Credit Suisse Vifor Pharma price target lowered to CHF 149 from CHF 152 at Credit Suisse 10/21/20 JPMorgan Vifor Pharma price target lowered to CHF 130 from CHF 175 at JPMorgan

Downgrade	Vifor Pharma downgraded to Sell from Neutral at UBS » 05:13 01/22/21 01/22 05:13 01/22/21 05:13 GNHAF Vifor Pharma $0.00 / + (+0.00%) UBS analyst Laura… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research GNHAF Vifor Pharma $0.00 / + (+0.00%) 11/09/20 Vifor Pharma, Angion sign licensing agreement for ANG-3777 commercialization 10/20/20 Vifor Pharma, Cara Therapeutics enter license agreement for Korsuva Injection GNHAF Vifor Pharma $0.00 / + (+0.00%) 01/04/21 JPMorgan Vifor Pharma downgraded to Underweight from Neutral at JPMorgan 10/22/20 Credit Suisse Vifor Pharma price target lowered to CHF 149 from CHF 152 at Credit Suisse 10/21/20 JPMorgan Vifor Pharma price target lowered to CHF 130 from CHF 175 at JPMorgan 10/21/20 UBS Vifor Pharma price target lowered to CHF 129 from CHF 142 at UBS
Earnings	Chemung Financial reports Q4 EPS $1.11, consensus $1.02 » 05:11 01/22/21 01/22 05:11 01/22/21 05:11 CHMG Chemung Financial $33.76 / -1.16 (-3.32%) Reports Q4 net… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings CHMG Chemung Financial $33.76 / -1.16 (-3.32%) 01/08/21 Chemung Financial announces 250,000 share repurchase program CHMG Chemung Financial $33.76 / -1.16 (-3.32%) 10/22/20 DA Davidson Chemung Financial downgraded to Neutral from Buy at DA Davidson 03/09/20 DA Davidson Chemung Financial upgraded to Buy from Neutral at DA Davidson CHMG Chemung Financial $33.76 / -1.16 (-3.32%) 10/19/20 Chemung Financial reports Q3 EPS $1.19, consensus 67c
Downgrade	Sage Therapeutics downgraded to Market Perform from Outperform at BMO Capital » 05:08 01/22/21 01/22 05:08 01/22/21 05:08 SAGE Sage Therapeutics $92.45 / +1.19 (+1.30%) BMO Capital analyst Gary… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events SAGE Sage Therapeutics $92.45 / +1.19 (+1.30%) 01/07/21 Sage Therapeutics plans to advance SAGE-319, SAGE-421 to preclinical studies 12/16/20 Sage Therapeutics names Barry Greene as CEO 11/27/20 Sage Therapeutics trading resumes 11/27/20 Sage Therapeutics to resume trading at 8 am ET SAGE Sage Therapeutics $92.45 / +1.19 (+1.30%) 01/19/21 Wedbush Sage Therapeutics price target raised to $98 from $83 at Wedbush 01/04/21 Sage Therapeutics downgraded to Sector Perform at RBC Capital on valuation 01/04/21 Guggenheim Sage Therapeutics upgraded to Buy from Neutral at Guggenheim 01/04/21 RBC Capital Sage Therapeutics downgraded to Sector Perform from Outperform at RBC Capital SAGE Sage Therapeutics $92.45 / +1.19 (+1.30%) 11/05/20 Sage Therapeutics reports Q3 EPS ($2.03), consensus ($2.39) 08/10/20 Sage Therapeutics reports Q2 EPS ($2.63), consensus ($2.66) SAGE Sage Therapeutics $92.45 / +1.19 (+1.30%) 12/04/20 Delta, United, Boeing downgrades among today's top calls on Wall Street 11/27/20 Fly Intel: Wall Street's top stories for Friday 11/27/20 Fly Intel: Pre-market Movers 03/01/21 41st Annual Healthcare Virtual Conference
Downgrade	Regis downgraded to Hold from Buy at Jefferies » 05:07 01/22/21 01/22 05:07 01/22/21 05:07 RGS Regis $9.25 / +0.195 (+2.15%) Jefferies analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly RGS Regis $9.25 / +0.195 (+2.15%) 12/02/20 Regis announces brand-centric reorganization 11/29/20 Fly Intel: Top five weekend stock stories 11/02/20 Regis falls -9.0% 11/02/20 Regis says about 80% of company's salon portfolio franchised at Q1-end RGS Regis $9.25 / +0.195 (+2.15%) 10/30/20 B. Riley Securities Regis price target raised to $160 from $155 at B. Riley Securities 10/22/20 Loop Capital Regis downgraded to Hold from Buy at Loop Capital 10/22/20 Loop Capital Regis downgraded to Hold from Buy at Loop Capital 06/19/20 Loop Capital Regis price target lowered to $15 from $21 at Loop Capital RGS Regis $9.25 / +0.195 (+2.15%) 11/02/20 Regis reports Q1 adjusted EPS (78c), consensus (12c) 08/31/20 Regis reports Q4 adjusted EPS ($1.01), consensus (66c) RGS Regis $9.25 / +0.195 (+2.15%) 11/28/20 Supercuts owner Regis stock a post-COVID play, Barron's says RGS Regis $9.25 / +0.195 (+2.15%) 11/02/20 Fly Intel: Pre-market Movers 08/31/20 Fly Intel: Wall Street's top stories for Monday 08/31/20 Fly Intel: Wall Street's top stories at midday 08/31/20 Fly Intel: Pre-market Movers
Upgrade	Seagate upgraded to Buy from Hold at Summit Insights » 05:07 01/22/21 01/22 05:07 01/22/21 05:07 STX Seagate $63.00 / +1.57 (+2.56%) Summit Insights analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Options STX Seagate $63.00 / +1.57 (+2.56%) 01/21/21 Seagate says 2020 'a very challenging year' 01/19/21 Nidec files patent infringement suit against Seagate 12/28/20 Seagate appoints Prat Bhatt to Board of Directors 12/16/20 Intel announces next generation of memory and storage products STX Seagate $63.00 / +1.57 (+2.56%) 05:04 Today Benchmark Seagate price target raised to $70 from $60 at Benchmark 01/21/21 Barclays Seagate price target raised to $60 from $41 at Barclays 01/20/21 Wedbush Seagate price target raised to $56 from $47 at Wedbush 01/19/21 Northland Seagate price target raised to $72 from $65 at Northland STX Seagate $63.00 / +1.57 (+2.56%) 01/21/21 Seagate sees Q3 adjusted EPS $1.30, plus/minus 15c, consensus $1.26 01/21/21 Seagate reports Q2 adjusted EPS $1.29, consensus $1.13 10/22/20 Seagate sees Q2 adjusted EPS $1.10, plus/minus 15c, consensus $1.08 10/22/20 Seagate reports Q1 adjusted EPS 93c, consensus 88c STX Seagate $63.00 / +1.57 (+2.56%) 01/21/21 Fly Intel: After-Hours Movers 12/28/20 Kinnate initiations, Nikola target change among today's top calls on Wall Street 10/23/20 Fly Intel: Wall Street's top stories for Friday 10/23/20 Fly Intel: Wall Street's top stories at midday STX Seagate $63.00 / +1.57 (+2.56%) 01/21/21 Seagate options imply 7.9% move in share price post-earnings 12/28/20 Largest borrow rate increases among liquid names 12/21/20 Seagate call volume above normal and directionally bullish 12/01/20 Seagate call volume above normal and directionally bullish

Events

Earnings calls, analyst events, roadshows and more

TBK
Today at 08:00

Triumph Bancorp - TBK Conference Calls
PPG
Today at 08:00

PPG - PPG Conference Calls
EDU
Today at 08:00

New Oriental Education - EDU Conference Calls
HBAN
Today at 08:30

Huntington Bancshares - HBAN Conference Calls
SLB
Today at 08:30

Schlumberger - SLB Conference Calls
BMTC
Today at 08:30

Bryn Mawr Bank - BMTC Conference Calls
KSU
Today at 08:45

Kansas City Southern - KSU Conference Calls
ALLY
Today at 09:00

Ally Financial - ALLY Conference Calls
TRST
Today at 09:00

Trustco Bank - TRST Conference Calls
DNMR
Today at 09:00

Danimer Scientific - DNMR Conference Calls

View All Events »

1 of

Syndicate

This week’s upcoming IPOs and secondary offerings

Priced
Not Priced

Mon	No deals
Tues	BDGE X BDGE Bridge Bancorp Block Trade Managers: Morgan Stanley Priced at: $25.50 700K Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial TCRR X TCRR TCR2 Therapeutics Secondary Managers: Goldman Sachs, Jefferies, Piper Sandler & BMO Capital Priced at: $30.50 4.59M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ACRS X ACRS Aclaris Therapeutics Spot Secondary Managers: Cantor Fitzgerald & William Blair, H.C. Wainwright Priced at: $17.50 5.484M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ACRX X ACRX AcelRx Spot Secondary Managers: Cantor Fitzgerald Priced at: $1.90 14.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial BLRX X BLRX BioLineRx Spot Secondary Managers: H.C. Wainwright Priced at: $2.40 12.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial BNGO X BNGO Bionano Genomics Spot Secondary Managers: Oppenheimer, BTIG, Ladenburg, Maxim Priced at: $6.00 33.333M Shares DSS X DSS Document Security Spot Secondary Managers: Aegis Priced at: $3.60 6.67M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial FULC X FULC Fulcrum Therapeutics Spot Secondary Managers: SVB Leerink, Piper Sandler & Credit Suisse Priced at: $11.00 4M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial LAC X LAC Lithium Americas Spot Secondary Managers: Canaccord, Deutsche Bank, Evercore ISI, Stifel Priced at: $22.00 15.9M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial PERI X PERI Perion Network Spot Secondary Managers: Oppenheimer, Stifel, Roth Capital, LAKE Priced at: $11.50 4.99M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SYRS X SYRS Syros Pharmaceuticals Spot Secondary Managers: Cowen & Piper Sandler Priced at: $14.00 5.4M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Wed	DFH X DFH Dream Finders Homes IPO Managers: BofA, RBC Capital & BTIG, Builder Advisor, Zelman, TCB Capital, Wedbush Priced at: $13.00 9.6M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial MYTE X MYTE Mytheresa IPO Managers: Morgan Stanley & JPMorgan, Credit Suisse, UBS, Jefferies, Cowen Priced at: $26.00 15.647M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ATHA X ATHA Athira Pharma Secondary Managers: Goldman Sachs, Jefferies, Stifel & JMP Securities Priced at: $22.50 4M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial CDNA X CDNA CareDx Secondary Managers: Goldman Sachs & Jefferies, Raymond James, BTIG, Craig-Hallum, H.C. Wainwright Priced at: $91.00 1.923M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial CMRX X CMRX Chimerix Secondary Managers: Jefferies & Cowen, H.C. Wainwright, JonesTrading Priced at: $8.50 11.765M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial CTMX X CTMX CytomX Therapeutics Secondary Managers: JPMorgan, Cowen & Piper Sandler Priced at: $7.00 14.286M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial DYN X DYN Dyne Therapeutics Secondary Managers: JPMorgan, Jefferies, Piper Sandler & Stifel Priced at: $28.00 6M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial EDIT X EDIT Editas Medicine Secondary Managers: JPMorgan & Morgan Stanley, Cowen, Credit Suisse Priced at: $66.00 3.5M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial MRUS X MRUS Merus Secondary Managers: Jefferies & SVB Leerink Priced at: $24.75 4.85M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial CYRX X CYRX Cryoport Spot Secondary Managers: Morgan Stanley, Jefferies, SVB Leerink & UBS Priced at: $66.00 3.788M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial INO X INO Inovio Spot Secondary Managers: BofA, Jefferies & Cantor Fitzgerald, Oppenheimer Priced at: $8.50 2.655M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ONCS X ONCS OncoSec Spot Secondary Managers: BTIG Priced at: $5.45 7.71M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ORC X ORC Orchid Island Capital Spot Secondary Managers: JPMorgan Priced at: $5.30 7.6M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Thurs	RLX X RLX RLX Technology IPO Managers: Citi, China Renaissance Priced at: $12.00 116.5M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial AZEK X AZEK Azek Secondary Managers: Barclays, BofA, Goldman Sachs & Jefferies Priced at: $40.00 20M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial CRSR X CRSR Corsair Gaming Secondary Managers: Goldman Sachs, Barclays, Credit Suisse, Macquarie, Baird, Cowen & Stifel, Wedbush, Academy Securities Priced at: $35.00 7.5M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial NVTA X NVTA Invitae Secondary Managers: JPMorgan, Morgan Stanley, Cowen & SVB Leerink Priced at: $51.50 7.77M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial PASG X PASG Passage Bio Secondary Managers: JPMorgan, Goldman Sachs & Cowen, Wedbush, Chardan Priced at: $22.00 7M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SI X SI Silvergate Capital Secondary Managers: Goldman Sachs, Keefe Bruyette & Canaccord, Compass Point, Craig-Hallum Priced at: $63.00 3.968M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ACB X ACB Aurora Cannabis Spot Secondary Managers: BMO Capital, ATB Capital Markets Priced at: $10.45 12M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Fri	No deals

Mon	No deals
Tues	No deals
Wed	No deals
Thurs	VRAY X VRAY ViewRay Block Trade Managers: Morgan Stanley $4.75-4.95 11.5M Shares PAX X PAX Patria IPO Managers: JPMorgan, BofA & Credit Suisse, Goldman Sachs, Bradesco BBI, BTG Pactual, ITAU, Keefe Bruyette, Santander, XP $14.00-16.00 26.65M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial DCBO X DCBO Docebo Secondary Managers: Morgan Stanley, Goldman Sachs & Canaccord $70.51 3.65M Shares GSL X GSL Global Ship Lease Spot Secondary Managers: Jefferies & B. Riley Securities $13.00-14.00 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial PGEN X PGEN Precigen Spot Secondary Managers: Wells Fargo & Stifel, JMP Securities, H.C. Wainwright $7.50-8.00 SENS X SENS Senseonics Spot Secondary Managers: H.C. Wainwright $2.42 25.974M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Fri	No deals

View All Syndicate Announcements »

MicroStrategy to hold a user conference

TODAY'S FREE FLY STORIES

Get Full Fly Access